REDUCTION OF SIGNAL FROM CONTAMINANT NUCLEIC ACIDS

1 . A method for bioinformatically distinguishing between a target sequence read, and a contaminant sequence read, said method comprising:

(a) providing a sample derived from a subject, wherein said sample comprises cell-free nucleic acids;

(b) subjecting said sample derived from said subject to a sequencing reaction to generate a plurality of sample sequence reads; and

(c) bioinformatically distinguishing a target sequence read from a contaminant sequence read in said plurality of sample sequence reads, wherein said target sequence read and said contaminant sequence read are derived from a same microbe or virus.

2 . The method of claim 1 , wherein said sample was subjected to a heating to inactivate contaminant nucleic acids prior to said sequencing reaction.

3 . The method of claim 1 , wherein said sample comprises blood, plasma serum, saliva. bronchoalveolar lavage, nasal swab, lymph, cerebrospinal fluid, urine, or any combination thereof.

4 . The method of claim 1 , wherein said plurality of sample sequence reads comprise host sequence reads, non-host sequence reads, or a combination thereof, and wherein said host sequence reads comprise human sequence reads and said non-host sequence reads comprise microbe or virus sequence reads.

5 . The method of claim 1 , wherein (c) comprises distinguishing said target sequence read from said contaminant sequence read based at least on identifying a presence of a sequence of said contaminant sequence read in a control sample.

6 . The method of claim 5 , wherein said contaminant readis derived from nucleic acids derived from an environmental contaminant.

7 . The method of claim 6 , wherein said nucleic acids derived from said environmental contaminant comprise non-host nucleic acids from an environmental pathogen.

8 . The method of claim 1 , wherein one or more microbes is present in said subject.

9 . The method of claim 8 , wherein said one or more microbes comprise a bacteria, a virus, a fungus, a parasite, or a combination thereof.

10 . The method of claim 1 , wherein said same microbe is selected from the group consisting of Bradyrhizobium, Rhizobium/Agrobacterium, Sphingomonas, Burkholderia, Ralstonia, Pseudomonas, Stenotrophomonas, Flavobacterium, Escherichia, Herbaspirillum, Methylobacteria, and any combination thereof.

11 . A bioinformatic method comprising distinguishing between a target sequence read and a contaminant sequence read, wherein said target sequence read and said contaminant sequence read are derived from a same microbe or virus.

12 . The method of claim 11 , wherein said plurality of sample sequence reads was generated by (i) providing a sample derived from a subject, wherein said sample comprises cell-free nucleic acids, (ii) heating said sample to inactivate contaminant nucleic acids, and (iii) sequencing said cell-free nucleic acids to generate said plurality of sample sequence reads, wherein said heating is performed prior to said sequencing.

13 . A nucleic acids sequencing system comprising:

(a) a nucleic acid sequencer;

(b) a nucleic acid analysis buffer;

(c) a heating element configured to hold a vessel comprising said nucleic acid analysis buffer, wherein said heating element is configured to heat said nucleic acid analysis buffer for a length sufficient to denature contaminant nucleic acids present in said nucleic acid analysis buffer; and

(d) a plurality of double-stranded adapters configured to attach to nucleic acids derived from a sample.

14 . The system of claim 13 , further comprising a computer comprising software that performs bioinformatic analysis on DNA or RNA sequence information.

15 . The system of claim 13 , wherein the nucleic acid sequencer comprises DNA sequencer or RNA sequencer for generating DNA or RNA sequence information.

16 . The system of claim 14 , wherein the bioinformatic analysis comprises assembling sequence data, detecting and/or quantifying genetic variants in a sample.

17 . The system of claim 14 , wherein the bioinformatic analysis comprises identifying germline variants and somatic cell variants.

18 . The system of claim 14 , wherein the DNA or RNA sequence information is analyzed to determine includes ploidy states.

19 . The system of claim 14 , wherein the DNA or RNA sequence information is used to identify genetic variants.

20 . The system of claim 19 , wherein the DNA or RNA sequence information is used to determine a quantitative measure of the variants, including relative and absolute relative measures.